United Kingdom· GB-APID-38109311000001105
Kigabeq 100mg soluble tablets
A vigabatrin product containing vigabatrin, registered in United Kingdom by Orphalan UK Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Vigabatrin is registered in 17 of 19 countries.
Countries holding a registration under ATC N03AG04 (vigabatrin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Vigabatrin · ATC N03AG04
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vigabatrin costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $3.20 in Italy to $12.93 in France — a ×4.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vigabatrin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- FR France$12.93
- CH Switzerland$3.45
- IT Italy$3.20
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Vigabatrin
- Manufacturer
- Orphalan UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- N03AG04
- ATC class
- Vigabatrin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin03770012922009
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
115 interactions on record for vigabatrin.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vigabatrin · interactions on record
115 records
- 31 severe
- 59 moderate
Most severe, free to view
- OxyquinolineA01AB07severe
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vigabatrin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumKigabeq 100 mgOrphelia Pharma
- SpainKIGABEQ 100 MG COMPRIMIDOS SOLUBLESOrphelia Pharma
- IrelandKigabeq 100 mg Soluble tabletOrphelia Pharma SA
- PolandKigabeqORPHELIA Pharma SAS
- SwedenKIGABEQ 100 mg Löslig tablettOrphelia Pharma SAS
- United StatesSABRILLundbeck Pharmaceuticals LLC
- NetherlandsKIGABEQ 100 mg, oplosbare tabletORPHELIA Pharma SA
- FinlandKigabeqORPHELIA Pharma SAS
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Sabril
- Belgium · Sabril
- Czechia · Sabril
- Germany · Sabril, Sabril Beutel
- Denmark · Sabrilex
- Spain · Sabrilex, Vigzip
- Finland · Sabrilex
- France · Sabril, Vigzip
- Greece · Sabril
- Hungary · Sabril
- Ireland · Sabril
- Iceland · Kigabeq, Sabrilex
- Italy · Sabril, Vigzip
- Liechtenstein · Kigabeq
- Luxembourg · Sabril
- Netherlands · Sabril, Sabril Filmomhulde Tablet
- Norway · Kigabeq, Sabrilex
- Poland · Sabril
- Portugal · Sabril
- Sweden · Sabrilex
- Slovenia · Sabril
- Slovakia · Sabril
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b9e7107-8e05-4cdc-9b26-a92b0d4cbbac GET /v1/drugs/8b9e7107-8e05-4cdc-9b26-a92b0d4cbbac?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38109311000001105",
"desc": "Kigabeq 100mg soluble tablets (Orphalan UK Ltd)",
"form": "Soluble tablet",
"vpid": "38286011000001103",
"source": "dmd",
"vtm_id": "777931009",
"strength": "100 mg",
"substance": "Vigabatrin",
"ingredient": "Vigabatrin",
"supplier_code": "39388311000001105"
}See everything about vigabatrin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.